Page last updated: 2024-08-24

mk 0591 and mdv 3100

mk 0591 has been researched along with mdv 3100 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bharathan, A; Ghosh, J; Monga, J; Subramani, D	1

Other Studies

1 other study(ies) available for mk 0591 and mdv 3100

Article	Year
Pharmacological and genetic targeting of 5-lipoxygenase interrupts c-Myc oncogenic signaling and kills enzalutamide-resistant prostate cancer cells via apoptosis. Scientific reports, 2020, 04-20, Volume: 10, Issue:1 Topics: 5-Lipoxygenase-Activating Protein Inhibitors; Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Benzamides; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Indoles; Male; Nitriles; Organ Specificity; Phenylthiohydantoin; Prostate; Proto-Oncogene Proteins c-myc; Quinolines; RNA, Small Interfering; Signal Transduction	2020

Article

Year

Pharmacological and genetic targeting of 5-lipoxygenase interrupts c-Myc oncogenic signaling and kills enzalutamide-resistant prostate cancer cells via apoptosis.

Scientific reports, 2020, 04-20, Volume: 10, Issue:1

Topics: 5-Lipoxygenase-Activating Protein Inhibitors; Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Benzamides; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Indoles; Male; Nitriles; Organ Specificity; Phenylthiohydantoin; Prostate; Proto-Oncogene Proteins c-myc; Quinolines; RNA, Small Interfering; Signal Transduction

2020